華天科技(002185.SZ):參設的江蘇盛宇人工智能創業投資完成工商登記註冊
格隆匯12月23日丨華天科技(002185.SZ)公佈,公司下屬企業西安天利投資合夥企業(有限合夥)(“西安天利”)擬與上海盛宇股權投資基金管理有限公司等共十二名出資人以現金出資方式共同投資設立江蘇盛宇人工智能創業投資合夥企業(有限合夥)(“產業基金”)。全體合夥人的認繳出資總額為5億元人民幣,其中西安天利作為有限合夥人,認繳出資5000萬元,認繳比例10%。
近日,該產業基金已完成工商登記註冊,並取得南京市溧水區行政審批局頒發的營業執照,名稱為江蘇盛宇人工智能創業投資合夥企業(有限合夥);經營範圍為創業投資、創業投資諮詢。(依法須經批准的項目,經相關部門批准後方可開展經營活動)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.